Gentaject vet. 100 mg/ml Injektionsvätska, lösning
Gentaject vet. 100 mg/ml Injektionsvätska, lösning
Authorised
- Gentamicin sulfate
Product identification
Medicine name:
Gentaject vet. 100 mg/ml Injektionsvätska, lösning
Active substance:
- Gentamicin sulfate
Target species:
-
Dog
-
Horse
Route of administration:
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Gentamicin sulfate120.50/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intravenous use
-
Horse
-
All relevant tissuesno withdrawal periodEj godkänt för användning till hästar som producerar kött eller mjölk för humankonsumtion.
-
-
-
Subcutaneous use
-
Horse
-
All relevant tissuesno withdrawal periodEj godkänt för användning till hästar som producerar kött eller mjölk för humankonsumtion.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01GB03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Sweden
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Franklin Pharmaceuticals Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Divasa Farmavic S.A.
- Franklin Pharmaceuticals Limited
Responsible authority:
- Swedish Medical Products Agency
Authorisation number:
- 11836
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Swedish (PDF)
Published on: 12/12/2025
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Swedish (PDF)
Published on: 12/12/2025
